JAMA Ophthalmology Journal Issues Research Articles in February 2023 Edition
February 17, 2023
February 17, 2023
CHICAGO, Illinois, Feb. 17 -- JAMA Ophthalmology, an international peer-reviewed journal on visual science from the American Medical Association, published research articles on the following topics in its February 2023 edition:
Original Investigations:
* Immunogenicity With Ranibizumab Biosimilar SB11 (Byooviz) and Reference Product Lucentis and Association With Efficacy, Safety, and Pharmacokinetics: A Post Hoc Analysis of a Phase 3 Randomized Clinical Trial
Original Investigations:
* Immunogenicity With Ranibizumab Biosimilar SB11 (Byooviz) and Reference Product Lucentis and Association With Efficacy, Safety, and Pharmacokinetics: A Post Hoc Analysis of a Phase 3 Randomized Clinical Trial